Lung Cancer | Heather Wakelee, MD

Biomarker Assessment and Targeted Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC) — Slide Presentation 3: Optimal Approach to Metastatic NSCLC with an EGFR Tumor Mutation After Disease Progression on Osimertinib — Dr Wakelee. CME information and select publications